|
![]() |
|||
|
||||
OverviewThis volume details the history of Retinitis Pigmentosa and current treatment options. Chapters guide readers through CRISPR, gene therapy, stem cell therapy, next-generation sequencing methods, gene editing, and translational applications of other therapies to the treatment of Retinitis Pigmentosa. Written in the successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Retinitis Pigmentosa aims to be a useful practical guide to researches to help further their study in this field. Full Product DetailsAuthor: Stephen H. Tsang , Peter M.J. QuinnPublisher: Springer-Verlag New York Inc. Imprint: Springer-Verlag New York Inc. Edition: 1st ed. 2023 Volume: 2560 Weight: 0.990kg ISBN: 9781071626504ISBN 10: 1071626507 Pages: 404 Publication Date: 09 December 2022 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1. Introduction and History of Retinitis Pigmentosa Hung-Hsi Wang, Nelson Chen, Nan-Kai Wang 2 Etiology of Retinitis Pigmentosa Mark P. Breazzano, Maeher Grewal, Stephen H. Tsang, and Royce W.S. Chen 3. Clinical Evaluation of Patients with Retinitis Pigmentosa Sitara H. Hirji 4. Molecular Genetic Testing Approaches for Retinitis Pigmentosa Megan Soucy, Akemi Joy Tanaka, and Avinash Dharmadhikari 5. Pedigree Analysis of Families and Patients Affected by Retinitis Pigmentosa Ioana Scherbakova and Sara D. Ragi 6. Whole Genome Sequencing for Detection of Structural Variants in Patients with Retinitis Pigmentosa Alexander H. Chai 7. Fundus Imaging Methodologies to Assess RP patients Jin Kyun Oh, Joseph Ryu, and Stephen H Tsang 8. The Use of Optical Coherence Tomography in Evaluation of Retinitis Pigmentosa Ha Min Kim, Jin Kyun Oh, Stephen H. Tsang 9. Optical Coherence Tomography Angiography (OCTA) findings in Retinitis Pigmentosa Vlad Diaconita and Wei Kiong Ngo 10. ERG to Evaluate the Retina in Cases of Retinitis Pigmentosa Wan-Chun Huang, Pei-Kang Liu, and Nan-Kai Wang 11. Visual Function Tests: Visual Fields Angela Y. Chang 12. Visual Function Tests Ritah Chumdermpadetsuk, Sara D. Ragi, and Stephen H. Tsang 13. Visual Acuity as a Measurement of Visual Function Zachary E. Snow 14. Measure of Visual Function Sitara H. Hirji 15. Ophthalmic Fluorescein Angiography Divin R. Baddam, Sara D. Ragi, Stephen H. Tsang, and Wei Kiong Ngo 16. Indocyanine Green Angiography Divin R. Baddam, Sara D. Ragi, Stephen H. Tsang, and Wei Kiong Ngo 17. Use of the Medmont Dark-Adapted Chromatic Perimeter for Assessing Rod Function in Retinitis Pigmentosa Yan Nuzbrokh, Sara Ragi, and Stephen H. Tsang 18. Multi-Luminance Mobility Testing Endpoint Henry W. Zhou 19. Preclinical Models of Retinitis Pigmentosa Mark D. Travor 20. ERG to evaluate the retina using mouse models Pei-Kang Liu, Wan-Chun Huang, and Nan-Kai Wang 21. Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent Chia-Hua Cheng and Xuan Cui 22. Large animal models of retinitis pigmentosa in therapy development and preclinical testing Laurence M Occelli and Simon M Petersen-Jones 23. CRISPR manipulations in stem cell lines Ya-Ju Chang, Xuan Cui, Sarah R. Levi, Laura A. Jenny, and Stephen H. Tsang 24. Metabolite extraction from RPE cells and retinas related to retinitis pigmentosa Xuan Cui, Ya-Ju Chang, Laura A. Jenny, Sarah R. Levi, Jianhai Du, and Stephen H. Tsang 25. CRISPR-mediated genome engineering in cell lines Ya-Ju Chang, Joseph Ryu, Xuan Cui, and Stephen H Tsang 26. CRISPR off-targeting Christine L. Xu, Merry Zhechao Ruan, Sara D. Ragi, and Stephen H. Tsang 27. CRISPR manipulations in stem cell lines Ya-Ju Chang, Xuan Cui, Sara D. Ragi, and Stephen H. Tsang 28. Generation of Human iPSC-Derived Retinal Organoids for Assessment of AAV-Mediated Gene Delivery Amy Tso, Bruna Lopes da Costa, Laura A. Jenny, Sarah R. Levi, Alexandra Fehnel, Sara D. Ragi, Yao Li, and Peter M.J. Quinn 29. Culture of Human Retinal Explants for Ex Vivo Assessment of AAV Gene Delivery Wen-Hsuan Wu, Amy Tso, Mark P. Breazzano, Sarah R. Levi, Laura A. Jenny, Stephen H. Tsang, and Peter M.J. Quinn 30. Prime Editing for the Installation and Correction of Mutations causing Inherited Retinal Disease: A Brief Methodology Yi-Ting Tsai, Bruna Lopes da Costa, Nicholas D. Nolan, Salvatore M. Caruso, Laura A. Jenny, Sarah R. Levi, Stephen H. Tsang, and Peter M.J. Quinn 31. Large scale single-nucleus RNA sequencing compatible with complex archived samples Chao-Yu Liu and Hsu-Hsin Chen 32. Vector Shedding and Immunogenicity Sampling in AAV-based Gene Therapy for Retinitis Pigmentosa Patients Ahra Cho 33. Current Management Options for Patients with Retinitis Pigmentosa Abinaya Thenappan 34. Challenges of Treatment Methodologies and the Future of Gene Therapy and Stem Cell Therapy to Treat Retinitis Pigmentosa Angela Y. Chang 35. Ocular Injection Techniques for Retinitis Pigmentosa: Intravitreal, Subretinal, and Suprachoroidal Ioana Scherbakova, Sara D. Ragi, and Tarun Sharma 36. Surgical Approach with Pars Plana Vitrectomy for Subretinal Gene Therapy Mark P. Breazzano, Sean A. Batson, Stephen H. Tsang, and Royce W.S. ChenReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |